Recursion

What began in 2013 as an idea stemming from the doctoral work of Chris Gibson, alongside co-founders Dr. Dean Li and Blake Borgeson, has blossomed into Recursion Pharmaceuticals, a clinical-stage TechBio company at the forefront of revolutionizing drug discovery. Initially ope…